← Back to Search

Healthy participants for Injection Site Reaction

N/A
Waitlist Available
Led By Marc C Torjman
Research Sponsored by Eitan Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject understands the English language, understands the risks, benefits, and alternatives to this research study, and is willing and able to give written informed consent.
Subject has no active signs/symptoms of a viral infection for 10 days prior to visit # 2.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial will test whether the SWI Device is safe and effective in healthy volunteers.

Eligible Conditions
  • Injection Site Reaction
  • Injection Site

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reliability of SWI
Secondary outcome measures
Incidences of Treatment Emergent Adverse Events of SWI
Pain
Other outcome measures
Overall experience of SWI

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy participantsExperimental Treatment1 Intervention
Up to 25ml of saline administered through OBI

Find a Location

Who is running the clinical trial?

Eitan MedicalLead Sponsor
Thomas Jefferson UniversityOTHER
442 Previous Clinical Trials
145,420 Total Patients Enrolled
Marc C TorjmanPrincipal InvestigatorThomas Jefferson University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively enrolling participants?

"Affirmative. Clinicaltrials.gov shows that this medical study, which was initially listed on August 23rd 2021, is actively recruiting individuals for participation. The trial necessitates 20 patients to be enrolled from one location."

Answered by AI

How many individuals have volunteered to participate in this experiment?

"Affirmative. According to clinicaltrials.gov, this research project began recruiting on August 23rd 2021 and has since been updated on January 20th 2022. The investigators are looking for a cohort of 20 patients from one medical institution."

Answered by AI

Which patient profiles are eligible to participate in this medical experiment?

"Eligible applicants for this clinical trial must have experienced infusion site reactions and be between 18-40 years old. Currently, there are 20 spots available."

Answered by AI

Can septuagenarians participate in this experiment?

"The inclusion criteria for this research program states that only individuals aged between 18 and 40 are eligible to participate. Nevertheless, there are still other trials available for those younger than 18 or older than 65 with 8 programs in total."

Answered by AI
~6 spots leftby Mar 2025